1989
DOI: 10.1111/j.1471-4159.1989.tb02526.x
|View full text |Cite
|
Sign up to set email alerts
|

AH5183 and Cetiedil: Two Potent Inhibitors of Acetylcholine Uptake into Isolated Synaptic Vesicles from Torpedo marmorata

Abstract: Synaptic vesicles purified on a sucrose-KCl sedimentation gradient were tested for their ability to accumulate [1-14C]acetylcholine ([1-14C]ACh) in the absence and in the presence of AH5183 and cetiedil. Kinetic studies of ACh transport showed that it was time dependent and saturable as a function of ACh concentration, with a KT of 1.2 mM. The protein-modifying agents N-ethylmaleimide and 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole were powerful inhibitors of ACh uptake. In agreement with other studies, AH5183 was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
11
0

Year Published

1990
1990
2001
2001

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 37 publications
(13 citation statements)
references
References 29 publications
2
11
0
Order By: Relevance
“…However, the number of human VAChT transporters expressed was greatly increased, and the B max (8.9 Ϯ 0.6 pmol/mg) was similar to that found for [ (27). Uptake was specifically inhibited by L-vesamicol, a noncompetitive inhibitor of vesicular ACh uptake in Torpedo (28,29), exhibiting an IC 50 of 14.7 Ϯ 1.5 nM (Fig. 3, inset).…”
Section: Resultsmentioning
confidence: 87%
“…However, the number of human VAChT transporters expressed was greatly increased, and the B max (8.9 Ϯ 0.6 pmol/mg) was similar to that found for [ (27). Uptake was specifically inhibited by L-vesamicol, a noncompetitive inhibitor of vesicular ACh uptake in Torpedo (28,29), exhibiting an IC 50 of 14.7 Ϯ 1.5 nM (Fig. 3, inset).…”
Section: Resultsmentioning
confidence: 87%
“…Expression of the Torpedo protein in mammalian fibroblasts confers high-affinity vesamicol binding to membranes isolated from transfected cells similar to that described on synaptic vesicles (7-20 nM( [19,35]. While the binding of vesamicol to synaptic vesicles from C. eleguns has never been reported, UNC-17 expressed separately in the same heterologous system demonstrated specific vesamicol binding as well, with lower affinity (-124 n&I) than that of Torpedo.…”
Section: Discussionmentioning
confidence: 92%
“…The inhibition constant of the transport of acetylcholine is similar to the dissociation constant of the drug, suggesting that binding and inhibition are directly related. However, inhibition is of the mixed non-competetive type [19,36] indicating that vesamicol does not bind to the a~etylcholine uptake site. Two models to account for this data have been proposed by Parsons and co-workers [37]: (i) vesamicol binds to an allosteric site on the vesicular acetylcholine transporter or (ii) vesamico1 binds to a different protein that acts by an unknown mechanism to inhibit acetylcholine uptake.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For VAChT, a reserpine-like competitive antagonist that can identify the high affinity acetylcholine recognition site does not exist. However, vesamicol acts as a specific noncompetitive inhibitor of vesicular acetylcholine transport with an inhibition constant (K i ) in the nanomolar range, similar to its dissociation constant (K d ) (51)(52)(53). Acetylcholine can competitively displace the binding of vesamicol with a K i 10 -100 times greater than the K m for acetylcholine transport (20,54).…”
Section: Several Sequence Alterations Occur At Conserved Residues Inmentioning
confidence: 99%